| scholarly article | Q13442814 |
| P50 | author | A J Richardson | Q68110511 |
| Vincent W T Lam | Q79181005 | ||
| P2093 | author name string | Henry C C Pleass | |
| Jerome M Laurence | |||
| Emma Johnston | |||
| Michael J Hollands | |||
| P2860 | cites work | Global cancer statistics, 2002 | Q27860562 |
| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration | Q27860647 | ||
| Two-stage liver surgery for advanced liver metastasis synchronous with colorectal tumor. | Q53625800 | ||
| Prospective Evaluation of Two-Stage Hepatectomy Combined with Selective Portal Vein Embolisation and Systemic Chemotherapy for Patients with Unresectable Bilobar Colorectal Liver Metastases | Q57781396 | ||
| Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases | Q60629746 | ||
| Resection of liver metastases--when is it worthwhile? | Q69254608 | ||
| Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie | Q71018196 | ||
| Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy | Q71656886 | ||
| Resection of colorectal liver metastases | Q72216092 | ||
| New frontiers in liver surgery. Two-stage liver surgery for the management of advanced metastatic liver disease | Q73084401 | ||
| Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors | Q73214550 | ||
| Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization | Q73630379 | ||
| Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results | Q73630382 | ||
| Simple pooling versus combining in meta-analysis | Q74426293 | ||
| Hepatic resection but not radiofrequency ablation results in tumor growth and increased growth factor expression | Q80212075 | ||
| Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity | Q81234867 | ||
| Two-stage hepatectomy for multiple bilobular liver metastases from colorectal cancer | Q81868968 | ||
| Two-stage hepatectomy: who will not jump over the second hurdle? | Q83240948 | ||
| Two-stage resection for bilobar colorectal liver metastases: R0 resection is the key | Q83380281 | ||
| Commentary on "Feasibility study of two-stage hepatectomy for bilobar liver metastases" | Q83426950 | ||
| Combined first-stage hepatectomy and colorectal resection in a two-stage hepatectomy strategy for bilobar synchronous liver metastases | Q84527160 | ||
| FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study | Q28189472 | ||
| Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases | Q33394252 | ||
| Tumour growth following portal branch ligation in an experimental model of liver metastases | Q33579175 | ||
| Traditional reviews, meta-analyses and pooled analyses in epidemiology | Q33589615 | ||
| Two-stage hepatectomy (R0) with portal vein ligation--towards curing patients with extended bilobular colorectal liver metastases | Q33690475 | ||
| What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up. | Q33865014 | ||
| Two-stage strategy for patients with extensive bilateral colorectal liver metastases. | Q33865026 | ||
| Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases | Q33874670 | ||
| Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer | Q33913953 | ||
| Portal vein embolization before right hepatectomy: prospective clinical trial | Q33964114 | ||
| Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? | Q34460461 | ||
| Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group | Q34511070 | ||
| Trends in long-term survival following liver resection for hepatic colorectal metastases | Q34523502 | ||
| Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial | Q34614245 | ||
| Actual 10-year survival after resection of colorectal liver metastases defines cure. | Q34699863 | ||
| High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome | Q34743458 | ||
| Evaluating agreement regarding the resectability of colorectal liver metastases: a national case-based survey of hepatic surgeons | Q36063258 | ||
| Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases | Q36867830 | ||
| Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases | Q36926232 | ||
| Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. | Q37303627 | ||
| The role of preoperative chemotherapy in patients with resectable colorectal liver metastases | Q37530660 | ||
| A systematic review of clinical response and survival outcomes of downsizing systemic chemotherapy and rescue liver surgery in patients with initially unresectable colorectal liver metastases | Q37933143 | ||
| Summary outcomes of two-stage resection for advanced colorectal liver metastases | Q38014795 | ||
| Resection of hepatic metastases from colorectal cancer. Biologic perspective | Q38671141 | ||
| Two-stage hepatectomy for multiple bilobar colorectal liver metastases | Q39734834 | ||
| Challenges in everyday surgical practice: synchronous bilobar hepatic colorectal metastases--newer multimodality approach. | Q40194186 | ||
| Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases | Q40264333 | ||
| Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial | Q42940352 | ||
| Feasibility study of two-stage hepatectomy for bilobar liver metastases | Q44479631 | ||
| Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). | Q45023757 | ||
| Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? | Q45166892 | ||
| Chemotherapy between the first and second stages of a two-stage hepatectomy for colorectal liver metastases: should we routinely recommend it? | Q45180622 | ||
| Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. | Q46029883 | ||
| Urgent need for a new staging system in advanced colorectal cancer. | Q46423656 | ||
| Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases | Q46538953 | ||
| Timing of two-stage liver resection during chemotherapy for otherwise unresectable colorectal metastases | Q47931380 | ||
| Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases | Q49186620 | ||
| Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. | Q53444980 | ||
| Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. | Q53522081 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systematic review | Q1504425 |
| hepatectomy | Q1514021 | ||
| P304 | page(s) | 483-491 | |
| P577 | publication date | 2012-11-07 | |
| P1433 | published in | Hepato Pancreato Biliary | Q15756742 |
| P1476 | title | A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases | |
| P478 | volume | 15 |
| Q49982491 | A Comparison of Pitfalls after ALPPS Stage 1 or Portal Vein Embolization in Small-for-Size Setting Hepatectomies |
| Q38808275 | A literature review of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): so far, so good |
| Q26800770 | A multidisciplinary approach for peritoneal carcinomatosis and bilobar liver metastases from colorectal cancer: case report and review of the literature |
| Q64235770 | A systematic review and meta-analysis of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) versus traditional staged hepatectomy |
| Q37686394 | ALPPS (associating liver partition and portal vein ligation for staged hepatectomy) does not affect proliferation, apoptosis, or angiogenesis as compared to standard liver resection for colorectal liver metastases |
| Q47951172 | ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: Results From a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial). |
| Q86874521 | ALPPS Offers a Better Chance of Complete Resection in Patients with Primarily Unresectable Liver Tumors. Results of a Multicentre Analysis: Reply |
| Q38837210 | ALPPS Procedure in Insufficient Hypertrophy After Portal Vein Embolization (PVE). |
| Q88394476 | ALPPS for Colorectal Liver Metastases |
| Q50080198 | An Overview of the Current Management of Bilobar Colorectal Liver Metastases |
| Q38852221 | An updated systematic review of the evolution of ALPPS and evaluation of its advantages and disadvantages in accordance with current evidence |
| Q97425681 | Associated liver partition and portal vein ligation for staged hepatectomy: a review |
| Q26765218 | Associating liver partition and portal vein ligation for staged hepatectomy: From technical evolution to oncological benefit |
| Q38963311 | Associating portal embolization and artery ligation to induce rapid liver regeneration in staged hepatectomy |
| Q89996822 | Cholangiocarcinoma: a site-specific update on the current state of surgical management and multi-modality therapy |
| Q91910135 | Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer |
| Q38240439 | Colorectal cancer with potentially resectable hepatic metastases: optimizing treatment |
| Q64098705 | Colorectal liver metastases: An update on multidisciplinary approach |
| Q38364613 | Contemporary surgical options for metastatic colorectal cancer |
| Q38631099 | Contribution of hepatobiliary scintigraphy in assessing ALPPS most suited timing |
| Q27690340 | Current position of ALPPS in the surgical landscape of CRLM treatment proposals |
| Q59811881 | Current status of surgical treatment of colorectal liver metastases |
| Q39293839 | Defining indications to ALPPS procedure: technical aspects and open issues |
| Q40184678 | Discrete improvement in racial disparity in survival among patients with stage IV colorectal cancer: a 21-year population-based analysis |
| Q37524976 | Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016. |
| Q28066171 | FIRST BRAZILIAN CONSENSUS ON MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 1: PRE-TREATMENT EVALUATION |
| Q90245737 | How to increase the resectability of initially unresectable colorectal liver metastases: A surgical perspective |
| Q48516132 | Hypertrophy and Liver Function in ALPPS: Correlation with Morbidity and Mortality |
| Q49744283 | Liver resection surgery versus thermal ablation for colorectal LiVer MetAstases (LAVA): study protocol for a randomised controlled trial |
| Q41100221 | Long-term results after in-situ split (ISS) liver resection |
| Q38217004 | Management of colorectal cancer presenting with synchronous liver metastases |
| Q38811107 | Management of patients with colorectal liver metastasis in eleven questions and answers |
| Q33770802 | Maximum Diameter and Number of Tumors as a New Prognostic Indicator of Colorectal Liver Metastases |
| Q40044052 | Molecular mechanisms of pathogenesis in hepatocellular carcinoma revealed by RNA‑sequencing |
| Q38238041 | Post hepatectomy liver failure: concept of management |
| Q57788525 | Prognostic factors of hepatectomy in initially unresectable colorectal liver metastasis: Indication for conversion therapy |
| Q52654017 | Radiofrequency ablation is beneficial in simultaneous treatment of synchronous liver metastases and primary colorectal cancer. |
| Q28083048 | Role of associating liver partition and portal vein ligation for staged hepatectomy in colorectal liver metastases: a review |
| Q58554455 | Role of associating liver partition and portal vein ligation in staged hepatectomy (ALPPS)-strategy for colorectal liver metastases |
| Q36747311 | Short-term outcomes after liver resection for malignant and benign disease in the age of ERAS. |
| Q38518258 | Staged resection of bilobar colorectal liver metastases: surgical strategies |
| Q39063517 | Strategies to Increase the Resectability of Patients with Colorectal Liver Metastases: A Multi-center Case-Match Analysis of ALPPS and Conventional Two-Stage Hepatectomy. |
| Q26738796 | Surgery for Colorectal Cancer - Trends, Developments, and Future Perspectives |
| Q28066809 | Surgery of Colorectal Liver Metastases: Pushing the Limits |
| Q58804376 | Synchronous colorectal liver metastases: a national survey of surgeon opinions on simultaneous resection and multidisciplinary cooperation |
| Q38275465 | Systematic review and meta-analysis of feasibility, safety, and efficacy of a novel procedure: associating liver partition and portal vein ligation for staged hepatectomy |
| Q41248852 | The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature review |
| Q95278037 | Transarterial chemoembolisation of colorectal liver metastases with irinotecan-loaded beads: What every interventional radiologist should know |
| Q35603852 | Tumour growth after portal vein embolization with pre-procedural chemotherapy for colorectal liver metastases |
| Q37333800 | Validation of the peak bilirubin criterion for outcome after partial hepatectomy. |
| Q34892632 | Volume regeneration of segments 2 and 3 after right portal vein embolization in patients undergoing two-stage hepatectomy |
Search more.